Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedVersion entries 681 and 682 were added, introducing Study Status and Contacts/Locations sections to the record history. This captures updates to the study's current status and contact/location details in the history timeline.SummaryDifference0.1%

- Check19 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.5.3, replacing the previous v3.5.2 entry. This records the latest version of the page in the history.SummaryDifference0.0%

- Check26 days agoChange DetectedThe displayed revision/version number updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page history now shows Revision: v3.4.2 added and Revision: v3.4.1 removed; this is a minor maintenance update that does not affect study records or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.